Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA)
CUSIP: 04746L104
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock, $0.0001 Par Value
- Shares outstanding
- 9,614,000
- Total 13F shares
- 24,736,986
- Share change
- -1,603,804
- Total reported value
- $253,318,555
- Put/Call ratio
- 205%
- Price per share
- $10.24
- Number of holders
- 86
- Value change
- -$61,367,283
- Number of buys
- 63
- Number of sells
- 27
Quarterly Holders Quick Answers
What is CUSIP 04746L104?
CUSIP 04746L104 identifies ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 04746L104:
Top shareholders of ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
36%
|
3,425,916
|
$63,037,000 | — | 31 Mar 2021 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
28%
|
2,652,553
|
$48,807,000 | — | 31 Mar 2021 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
22%
|
2,120,653
|
$39,020,000 | — | 31 Mar 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
20%
|
1,885,901
|
$34,701,000 | — | 31 Mar 2021 | |
| VR Adviser, LLC |
13F
|
Company |
18%
|
1,691,623
|
$31,126,000 | — | 31 Mar 2021 | |
| Avidity Partners Management LP |
13F
|
Company |
17%
|
1,677,845
|
$30,872,000 | — | 31 Mar 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
13%
|
1,263,070
|
$23,240,000 | — | 31 Mar 2021 | |
| Logos Global Management LP |
13F
|
Company |
11%
|
1,010,812
|
$18,599,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
10%
|
990,449
|
$18,224,000 | — | 31 Mar 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
9.1%
|
875,639
|
$15,879,000 | — | 31 Mar 2021 | |
| WASATCH ADVISORS LP |
13F
|
Company |
8.4%
|
808,215
|
$14,871,000 | — | 31 Mar 2021 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
8.4%
|
806,367
|
$14,837,000 | — | 31 Mar 2021 | |
| Rock Springs Capital Management LP |
13F
|
Company |
8.2%
|
788,202
|
$14,503,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.1%
|
779,468
|
$14,342,000 | — | 31 Mar 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
7%
|
672,962
|
$12,383,000 | — | 31 Mar 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
5.3%
|
510,395
|
$9,391,000 | — | 31 Mar 2021 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
5.3%
|
509,168
|
$9,369,000 | — | 31 Mar 2021 | |
| PATHSTONE FAMILY OFFICE, LLC |
13F
|
Company |
5.2%
|
499,416
|
$9,189,000 | — | 31 Mar 2021 | |
| PFM Health Sciences, LP |
13F
|
Company |
4.9%
|
470,227
|
$8,652,000 | — | 31 Mar 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
4.6%
|
443,200
|
$8,155,000 | — | 31 Mar 2021 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
4.2%
|
400,000
|
$7,360,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.6%
|
248,561
|
$4,573,000 | — | 31 Mar 2021 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
212,351
|
$3,907,000 | — | 31 Mar 2021 | |
| KAYNE ANDERSON CAPITAL ADVISORS LP |
13F
|
Company |
2%
|
190,216
|
$3,498,000 | — | 31 Mar 2021 | |
| S Squared Technology, LLC |
13F
|
Company |
1.9%
|
181,220
|
$3,334,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.6%
|
152,585
|
$2,808,000 | — | 31 Mar 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
1.4%
|
131,995
|
$2,429,000 | — | 31 Mar 2021 | |
| Pentwater Capital Management LP |
13F
|
Company |
1.2%
|
120,000
|
$2,208,000 | — | 31 Mar 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.2%
|
111,268
|
$2,048,000 | — | 31 Mar 2021 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.95%
|
91,531
|
$1,684,000 | — | 31 Mar 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.63%
|
60,088
|
$1,106,000 | — | 31 Mar 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.54%
|
51,700
|
$951,000 | — | 31 Mar 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.5%
|
47,999
|
$883,000 | — | 31 Mar 2021 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.47%
|
44,828
|
$825,000 | — | 31 Mar 2021 | |
| STRS OHIO |
13F
|
Company |
0.39%
|
37,500
|
$690,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.37%
|
35,678
|
$656,000 | — | 31 Mar 2021 | |
| Clarius Group, LLC |
13F
|
Company |
0.34%
|
32,825
|
$604,000 | — | 31 Mar 2021 | |
| HighVista Strategies LLC |
13F
|
Company |
0.33%
|
32,062
|
$590,000 | — | 31 Mar 2021 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.27%
|
25,790
|
$475,000 | — | 31 Mar 2021 | |
| Lindbrook Capital, LLC |
13F
|
Company |
0.26%
|
24,927
|
$459,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.23%
|
22,445
|
$413,000 | — | 31 Mar 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.22%
|
20,933
|
$385,000 | — | 31 Mar 2021 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.21%
|
20,452
|
$381,000 | — | 31 Mar 2021 | |
| AlphaCentric Advisors LLC |
13F
|
Company |
0.21%
|
20,538
|
$378,000 | — | 31 Mar 2021 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.19%
|
17,900
|
$329,000 | — | 31 Mar 2021 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.16%
|
15,180
|
$279,000 | — | 31 Mar 2021 | |
| Creative Planning |
13F
|
Company |
0.14%
|
13,255
|
$244,000 | — | 31 Mar 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.13%
|
12,900
|
$237,000 | — | 31 Mar 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.13%
|
12,228
|
$225,000 | — | 31 Mar 2021 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.12%
|
11,766
|
$216,000 | — | 31 Mar 2021 |
Institutional Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q2 2021
As of 30 Jun 2021,
Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,736,986 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, FRANKLIN RESOURCES INC, BlackRock Inc., RTW INVESTMENTS, LP, VR Adviser, LLC, Logos Global Management LP, VANGUARD GROUP INC, WASATCH ADVISORS INC, CITADEL ADVISORS LLC, and BAKER BROS. ADVISORS LP.
This page lists
86
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
68
Q2 2021 holders
86
Holder diff
18
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.